Stable Health Reported 2026-11-17 22:50 Isomorphic Labs raises $5B for drug discovery Isomorphic Labs, an AI drug-discovery platform, raises $5B in a Series C funding round to advance its drug candidates into clinical trials.
Why it matters. The funding will accelerate the development of new drugs, potentially benefiting patients and the pharmaceutical industry.
Primary entity
Isomorphic Labs
Company
01
Who and what it touches Alphabet invests in Greenoaks finances artificial intelligen… uses London located in bioresilience enables IsoDDE produces MSD partners with Lilly serves Isomorphic Labs Each line is a relation with evidence behind it, drawn in the direction it points. A line shows that two things are connected, not how far this change reaches.